Procter & Gamble Health Ltd share price logo

Procter & Gamble Health Ltd

NSE: PGHL

BSE: 500126

Small Cap

Pharma Sector

₹6068.00

-396.50

(-6.13%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

🔔 Earnings Alert

Procter & Gamble Health reports Q1 FY27 net profit up 45% to Rs 96 crore and revenue up 7%, driven by strong brand and supply chain.

Procter & Gamble Health Stock Performance

as on August 6, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹5,980.00
    ₹6,670.00
    downward going graph

    1.45%

    Downside

    9.92%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹4,707.00
    ₹6,975.00
    downward going graph

    22.43%

    Downside

    14.95%

    Upside

    downward going graph

Procter & Gamble Health share price movements today

Previous Close
₹6,464.50
Open
₹6,460.00
Volume
1.45L
Upper Circuit
₹7,757.00
Lower Circuit
₹5,172.00
Day's Low - High
₹5,980.00 - ₹6,670.00
52 Week Low - High
₹4,707.00 - ₹6,975.00

Procter & Gamble Health Historical Returns

1 Month Return
+ 1.79 %
3 Month Return
+ 21.09 %
1 Year Return
+ 5.07 %
3 Year Return
+ 21.55 %
5 Year Return
+ 18.14 %

Procter & Gamble Health Fundamentals

as on August 6, 2026 at 4:01 pm IST

Market Cap

₹10,730.67 Cr

Return on Equity (ROE)

58.14

PE Ratio (TTM)

32.82

Return on capital employed (ROCE)

71.75

Industry PE ratio

52.28

Beta (LTM)

0.43

P/B Ratio

15.9

Dividend Yield

0

PEG Ratio

0.71

Quarterly Earnings Growth YOY

45.29

EPS (TTM)

0

Book Value

0

Procter & Gamble Health Stock Valuation

as on August 6, 2026 at 4:01 pm IST

Procter & Gamble Health in the last 5 years

  • Overview

  • Trends

Lowest (24.26x)

April 2, 2026

Today (32.82x)

August 5, 2026

Industry (52.28x)

August 5, 2026

Highest (59.12x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: 32.82x

Procter & Gamble Health Technical Analysis

Track how Procter & Gamble Health technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish13
Bullish1
Neutral1

Oscillators

Name

Value

Action

MACD level (12,26)
-11.37
Bearish
CCI (20)
538.38
Bearish
RSI (14)
36.61
Neutral
Momentum (10)
-21
Bullish
ADI (14)
28.54
Bearish
Ultimate Oscillator (7,14,28)
7.92
Bearish

Moving Averages

Name

Value

Action

SMA (20)
6081.8
Bearish
EMA (20)
6079.46
Bearish
VWMA (20)
6075.08
Bearish
SMA (50)
6097.61
Bearish
EMA (50)
6107.32
Bearish
SMA (200)
6350.47
Bearish
EMA (200)
6287.1
Bearish
KAMA (200)
6102.19
Bearish
DEMA (200)
6130.04
Bearish

Procter & Gamble Health Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Procter & Gamble Health with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Procter & Gamble Health Ltd image
Procter & Gamble Health Ltd
BUY10,730.673.63%0.00234934
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
HOLD16,429.35-5.17%0.682641,197
Jubilant Pharmova Ltd image
Jubilant Pharmova Ltd
BUY14,730.477.7%0.713978,279
Sun Pharma Advanced Research Company Ltd image
Sun Pharma Advanced Research Company Ltd
BUY7,085.93-4.69%0.661,5531,879
Rainbow Childrens Medicare Ltd image
Rainbow Childrens Medicare Ltd
BUY16,236.4451.02%0.682811,703
See all

Market expectation of Procter & Gamble Health Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Procter & Gamble Health Stock’s Investor Sentiment and Interest

Search interest for Procter & Gamble Health Ltd Stock has increased by 28% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:28% versus previous 30 day period

Procter & Gamble Health Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
304.93
309.97
252.48
283.88
313.41
309.77
310.99
338.74
324.92
373.86
370.45
363.71
Other Income
6.05
5.18
2.27
2.13
3.28
3.96
3.11
4.03
4.95
4.36
4
35.68
Total Income
310.98
315.15
254.75
286.01
316.69
313.73
314.1
342.77
329.87
378.22
374.45
399.39
Expenses
216.27
208.32
185.04
255.82
199.37
186.34
230.07
248.4
204.65
263.4
234.86
264.11
Operating Profit
88.66
101.65
67.44
28.06
114.04
123.43
80.92
90.34
120.27
110.46
135.59
99.6
Operating Profit Margin %
29.08%
32.79%
26.71%
9.88%
36.39%
39.85%
26.02%
26.67%
37.02%
29.55%
36.6%
27.38%
Profit Before Interest, Tax and Depreciation
94.71
106.83
69.71
30.19
117.32
127.39
84.03
94.37
125.22
114.82
139.59
135.28
Interest
0.18
0.19
0.15
0.2
0.15
0.15
0.13
0.12
0.12
0.1
0.21
0.14
Depreciation
6.48
6.92
6.84
7.16
5.77
5.55
5.37
5.44
6.08
5.9
6.17
6.02
Profit Before Tax
88.05
99.72
62.72
22.83
111.4
121.69
78.53
88.81
119.02
108.82
133.21
129.12
Tax Paid
22.48
27.65
16.16
6.05
29.07
30.79
17.35
22.63
30.48
31.23
38.61
32.97
Profit After Tax
65.57
72.07
46.56
16.78
82.33
90.9
61.18
66.18
88.54
77.59
94.6
96.15
Total Net profit including share of profit / Loss from associate company
65.57
72.07
46.56
16.78
82.33
90.9
61.18
66.18
88.54
77.59
94.6
96.15
EPS
39.5
43.4
28
9.5
49.6
54.76
36.86
39.87
53.34
46.74
56.99
57.92
Actual EPS
39.5
43.4
28
9.5
49.6
54.76
36.86
39.87
53.34
46.74
56.99
57.92
Adjusted EPS
39.5
43.4
28
9.5
49.6
54.76
36.86
39.87
53.34
46.74
56.99
57.92
Diluted EPS
39.5
43.4
28
9.5
49.6
54.76
36.86
39.87
53.34
46.74
56.99
57.92

Procter & Gamble Health Ltd Annual Profit & Loss

Figures in Rupees Crores

Dec 2017
Dec 2018
Mar 2020
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Mar 2025
Mar 2026
Sales
698.13
849
1,154.7
1,355.86
1,008.73
1,114.41
1,229.62
1,151.26
934.17
1,407.97
Other Income
73.94
767.93
58.21
68.89
18.1
13.19
18.39
15.63
10.35
17.34
Total Income
772.07
1,616.93
1,212.91
1,424.75
1,026.83
1,127.6
1,248.01
1,166.89
944.52
1,425.31
Expenses
621.16
700.85
892.39
1,040.45
762.71
846.73
904.94
865.45
615.78
951.31
Operating Profit
76.97
148.15
262.31
315.41
246.02
267.68
324.68
285.81
318.39
456.66
Operating Profit Margin %
11.03%
17.45%
22.72%
23.26%
24.39%
24.02%
26.4%
24.83%
34.08%
32.43%
Profit Before Interest, Tax and Depreciation
150.91
916.08
320.53
384.3
264.12
280.87
343.07
301.44
328.74
474
Interest
-
-
-
-
0.8
0.42
0.77
0.72
0.43
0.55
Depreciation
19.12
21.12
21.4
29.45
30.04
27.08
28.1
27.4
16.69
23.59
Profit Before Tax
131.79
894.96
299.13
354.85
233.28
253.37
314.2
273.32
311.62
449.86
Tax Paid
37.88
56.25
93.91
100.77
56.48
60.85
84.73
72.34
77.21
122.95
Profit After Tax
93.91
838.72
205.22
254.08
176.8
192.52
229.47
200.98
234.41
326.91
Total Net profit including share of profit / Loss from associate company
93.91
838.72
205.22
254.08
176.8
192.52
229.47
200.98
234.41
326.91
EPS
56.57
505.27
123.63
153.1
106.5
115.98
138.23
121.07
141.22
196.94
Actual EPS
56.57
505.27
123.63
153.1
106.5
115.98
138.23
121.07
141.22
196.94
Adjusted EPS
56.57
505.27
123.63
153.1
106.5
115.98
138.23
121.07
141.22
196.94
Diluted EPS
56.57
505.27
123.63
153.1
106.5
115.98
138.23
121.07
141.22
196.94

Procter & Gamble Health Ltd Cash Flow

Figures in Rupees Crores

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Mar 2025
Net Cash from Operating Activities
83.47
107.04
53.66
-130.39
235.37
247.26
169.52
236.01
228.29
168.69
Cash Flow from Investing Activities
-67.84
-74.97
-47.63
1,269.72
164.64
-32.27
-25.54
-21.5
-6.87
9.59
Cash Flow from Financing Activities
-11.92
-14.98
-21.98
-30.12
-883.41
-386.63
-288.63
-98.49
-418.11
-234.74
Net Cash Flow
3.71
17.09
-15.95
1,109.21
-483.4
-171.64
-144.65
116.02
-196.69
-56.46

Procter & Gamble Health Stock Shareholding Pattern

Numbers in percentages

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
51.82%
51.82%
51.82%
51.82%
51.82%
51.82%
51.82%
51.82%
51.82%
51.82%
51.82%
51.82%
DII
12.13%
12.67%
13.73%
14.55%
14.84%
14.71%
14.21%
14.16%
13.91%
13.84%
13.68%
12.44%
FII
0%
7.59%
6.24%
6.4%
6.61%
7.02%
6.87%
6.99%
7.24%
6.97%
6.2%
6.33%
Public
28.49%
27.92%
28.21%
27.23%
26.74%
26.46%
27.11%
27.03%
27.04%
27.37%
28.31%
29.42%
Total Outstanding Shares
1,65,99,382
1,65,99,382
1,65,99,382
1,65,99,382
1,65,99,382
1,65,99,382
1,65,99,382
1,65,99,382
1,65,99,382
1,65,99,382
1,65,99,382
1,65,99,382
Total Shareholders
57,919
56,730
56,778
55,923
54,792
53,736
53,993
52,478
50,006
49,302
50,883
49,056

Mutual Funds that own Procter & Gamble Health Stock

Check out the Mutual Funds with significant holdings in Procter & Gamble Health.

Procter & Gamble Health Corporate Actions

View detailed summary of the earnings and dividend history of Procter & Gamble Health.

  • Procter & Gamble Health Ltd Earnings Results

    Procter & Gamble Health Ltd’s net profit jumped 54.63% since last year same period to ₹94.60Cr in the Q4 2025-2026. On a quarterly growth basis, Procter & Gamble Health Ltd has generated 21.92% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Procter & Gamble Health Ltd Dividends May,2026

    In the quarter ending March 2026, Procter & Gamble Health Ltd has declared dividend of ₹45.00 per share on 26 May 2026 - translating a dividend yield of 3.87%.

    Read More about Dividends

Procter & Gamble Health News & Key Events

  • img

    Today's Timeline - 06 August

    04:01 PM

    -

    Procter & Gamble Health reports Q1 sales of Rs 356 crore and 45% PAT increase year-over-year.

Indices Featuring Procter & Gamble Health Stock

Check stock indices that include Procter & Gamble Health.

BSE Healthcare

₹50,982.31

20.12 (▲0.04%)

Insights on Procter & Gamble Health Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 28.31% to 29.42% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, PGHL stock has moved up by 21.1%

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 6.20% to 6.33% in Jun 2026 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 51.82% of holdings in Jun 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 41.9% return, outperforming this stock by 36.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 143.7% return, outperforming this stock by 122.2%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 10.20% to 9.05% in Jun 2026 quarter

About Procter & Gamble Health Ltd

Procter and Gamble Health Limited, formerly Merck Limited, is a 51% subsidiary of German firm Merck KGaA and is based in India. It is engaged in the manufacturing and marketing of pharmaceuticals, chemicals, biotechnology products, and consumer health products. The company operates in two divisions: Pharmaceuticals and Chemicals. Pharmaceuticals include Ethicals for treatment of cardiovascular and metabolic diseases, Vitamin-based Formulations, and Consumer Healthcare products. Chemicals division consists of Bulk Drugs and Pigments. It was incorporated in 1967 as E Merck India Ltd and changed its name to Merck Ltd in 2002. In 2018, Merck Life Science Private Limited acquired the Biopharma Performance Materials and Life Science Segments of Merck Ltd for Rs 1,05,200 lakhs. This shifted the company's main focus to manufacturing and marketing pharmaceuticals. The company has expanded its production capacity of Bulk Drugs by 18 tonnes to 479 tonnes, Injection/Nasal Drops by 24 kiloliters to 440 kiloliters, and Tablets/Capsules by 40 million Nos to 400 million Nos. It has launched various products such as Pedimune, Glimepiride, Acrobat and Ziflam, Livogen CZ, Polybion Complete Syrup, Met Neurobion Injection, Evion Forte, Olmighty and Whisper Choice Aloe Vera Tablets, Neurobion Forte, and Livogen Iron and Multivitamin Tonic etc. However, its growth has been affected by the ban on 344 fixed drug combinations, demand notice from National Pharmaceutical Pricing Authority and writ petition filed by Credence Pharmaceuticals Private Limited. The company has challenged the ban and demands and hopes for a positive outcome.

Revenue: ₹363.71Cr as on June 2026 (Q1 FY27)
Net Profit: ₹96.15Cr as on June 2026 (Q1 FY27)
Listing date: 08 Nov, 1994
Chairperson Name: S N Talwar
OrganisationProcter & Gamble Health Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOS N Talwar
E-voting on sharesClick here to vote

FAQs

What is Procter & Gamble Health share price today?

Procter & Gamble Health share price today stands at ₹6068 as on at the close of the market. Procter & Gamble Health share today touched a day high of ₹6670 and a low of ₹5980.

What is the 52 week high and 52 week low range for Procter & Gamble Health share?

Procter & Gamble Health touched a 52 week high of ₹6975 and a 52 week low of ₹4707. Procter & Gamble Health share price today i.e. is closed at ₹6068, which is -13.00% down from its 52 week high and 28.91% up from its 52 week low.

What is Procter & Gamble Health's market capitalisation today?

Procter & Gamble Health market capitalisation is ₹10,730.67 Cr as on .

How to buy Procter & Gamble Health shares?

To buy Procter & Gamble Health shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for PGHL or Procter & Gamble Health Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Procter & Gamble Health shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Procter & Gamble Health trading volume today?

Procter & Gamble Health trading volume is 1.45L as on . This means that 1.45L shares of Procter & Gamble Health were bought and sold on the stock market during today's trading session.